Literature DB >> 24786149

High dose EPO--friend or foe in the newborn?

Helen G Liley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24786149      PMCID： PMC4230765          DOI： 10.1113/jphysiol.2014.274522

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  5 in total

1.  Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain.

Authors:  Myriam Bernaudin; Anne-Sophie Nedelec; Didier Divoux; Eric T MacKenzie; Edwige Petit; Pascale Schumann-Bard
Journal:  J Cereb Blood Flow Metab       Date:  2002-04       Impact factor: 6.200

2.  Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells.

Authors:  Angus M Sinclair; Angela Coxon; Ian McCaffery; Stephen Kaufman; Katherine Paweletz; Liqin Liu; Leigh Busse; Susan Swift; Steven Elliott; C Glenn Begley
Journal:  Blood       Date:  2010-02-02       Impact factor: 22.113

Review 3.  Differentiating factors between erythropoiesis-stimulating agents: an update to selection for anaemia of chronic kidney disease.

Authors:  Walter H Hörl
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

Review 4.  Erythropoietins: a common mechanism of action.

Authors:  Steve Elliott; Elizabeth Pham; Iain C Macdougall
Journal:  Exp Hematol       Date:  2008-10-14       Impact factor: 3.084

5.  Prophylactic erythropoietin exacerbates ventilation-induced lung inflammation and injury in preterm lambs.

Authors:  Graeme R Polglase; Samantha K Barton; Jacqueline M Melville; Valerie Zahra; Megan J Wallace; Melissa L Siew; Mary Tolcos; Timothy J M Moss
Journal:  J Physiol       Date:  2014-03-03       Impact factor: 5.182
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.